(Q70276144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

nephrogenic diabetes insipidus

10 October 2019

main subject

1 reference

S Libber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

H Harrison

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

D Spector

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 February 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

305-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

Demonstration of a defect in the formation of adenosine 3',5'-monophosphate in vasopressin-resistant diabetes insipidus.

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Nephrogenic diabetes insipidus. Effects of 3,5, cyclic-adenosine monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

The Effect of Exogenous 3′: 5′-Adenosine Monophosphate on Urinary Output in Children with Vasopressin-Resistant Diabetes Insipidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Clinical results of treatment of diabetes insipidus with drugs of the chlorothiazide series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

INVESTIGATIONS INTO THE THIAZIDE-INDUCED ANTIDIURESIS IN PATIENTS WITH DIABETES INSIPIDUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Effect of Prostaglandin (PGEI) on the Permeability Response of Toad Bladder to Vasopressin, Theophylline and Adenosine 3′,5′-monophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3',5'-monophosphate, and theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Effect of PGE1, indomethacin, and polyphloretin phosphate on toad bladder response to ADH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Renal prostaglandin E2 in nephrogenic diabetes insipidus: effects of inhibition of prostaglandin synthesis by indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Tolmetin sodium in the management of nephrogenic diabetes insipidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Vasopressin in osmotic regulation in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Effects of indomethacin on renal inner medullary plasma flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Effects of indomethacin on intrarenal blood flow and medullary osmolality in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

The antidiuretic effect of chronic hydrochlorothiazide treatment in rats with diabetes insipidus: renal mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Hyperuricemia, a concomitant of congenital vasopressin-resistant diabetes insipidus in the adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981010-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(86)81010-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3080575%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference